4

Investors

SEC Filing Details

Document Details

Form
Filing Date
Jun 26, 2020
Document Date
Jun 25, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Arrowhead Pharmaceuticals Inc.
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
Filer
Anzalone Christopher Richard